You are here: Industry Insights > Organon

News List

Organon to Acquire Forendo Pharma AmericanPharmaceuticalReview
November 12, 2021
Organon and Forendo Pharma announced that the companies have entered into a definitive agreement, under which Organon will acquire Forendo, a clinical-stage drug development company...
Organon and ObsEva to collaborate on preterm labour treatment pharmatimes
July 28, 2021
Women’s health company Organon has signed a license agreement with Swiss biopharma company ObsEva to develop a potential treatment for preterm labour.
Organon and ObsEva Agree to Develop and Commercialize Treatment for Preterm Labor americanpharmaceuticalreview
July 28, 2021
Organon announced an agreement where Organon will license the global development, manufacturing and commercial rights to ebopiprant (OBE022).
Organon Acquires Alydia Health americanpharmaceuticalreview
June 18, 2021
Organon, a global women’s healthcare company, announced the completion of its acquisition of Alydia Health, a commercial-stage medical device company focused on preventing maternal morbidity and mortality caused by postpartum hemorrhage (PPH) or ...
Organon Launches as New Global Women’s Health Company americanpharmaceuticalreview
June 07, 2021
Organon celebrates its launch as a global women’s health company with employees and women from around the world, as the Organon executive leadership team rings the opening bell at the New York Stock Exchange.
Merck completes spinoff of women’s health company Organon pharmaceutical-technology
June 07, 2021
Merck (MSD) has completed the spinoff of Organon to boost its focus on growth areas, realise higher revenue and earnings per share (EPS) growth rates.
Organon launches as Women’s Health company expresspharma
June 04, 2021
Organon is a new company focused on women’s health. In India, Organon will be operating in women’s healthcare, fertility, dermatology, respiratory and bone health products in their portfolio.